855 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva bullish on synergies of Allergan deal, sees annual EBITDA growth of 14% through 2019; shares up 3% premarket http://seekingalpha.com/news/3192964-teva-bullish-synergies-allergan-deal-sees-annual-ebitda-growth-14-percent-2019-shares-3?source=feed_news_all Jul 13, 2016 - Teva's (TEVA) corporate presentation this morning has perked up investors. Shares are up 3% premarket on robust volume. CEO Erez Vigodman said that there a
Teva Raises Q2 Guidance; to Unveil 2016-2019 View http://www.zacks.com/stock/news/223261/teva-raises-q2-guidance-to-unveil-2016-2019-view?cid=CS-ZC-FT-223261 Jul 13, 2016 - Ahead of its acquisition of Allergan's Generics business, Teva Pharmaceutical (TEVA) raised its second-quarter 2016 guidance for earnings and revenues.
Buy Into Teva's Uncertainty? http://seekingalpha.com/article/3978556-buy-tevas-uncertainty?source=feed_tag_israel May 30, 2016 - Many investors and analysts alike still have doubts over the impending Allergan deal. I still believe over the long term that it will turn out to be a success.Teva's forward price to earnings ratio lo
Teva: Stronger Than Ever? http://seekingalpha.com/article/3977496-teva-stronger-ever?source=feed_tag_israel May 24, 2016 - Teva Pharma has had a tough go of it as of late.Regulatory hurdles and challenges to its existing commercial line-up have given investors a headache.Potential opportunities are running rampant with it
John Keeley Comments on Teva Pharmaceuticals http://www.gurufocus.com/news/409361/john-keeley-comments-on-teva-pharmaceuticals Apr 26, 2016 - John Keeley Comments on Teva Pharmaceuticals, Stocks: TEVA, John Keeley, release date:Apr 26, 2016
Allergan: Pfizer Deal Collapse Opens Door To Teva Deal http://seekingalpha.com/article/3963802-allergan-pfizer-deal-collapse-opens-door-teva-deal?source=feed_tag_long_ideas Apr 07, 2016 - Allergan's failed merger with Pfizer should set the table for its other mega-deal with Teva to close.Regulators no longer need to worry about ways to keep Pfizer in the US.Pfizer will probably spin of
Teva Offers A Smoother Climb http://seekingalpha.com/article/3963344-teva-offers-smoother-climb?source=feed_all_articles Apr 05, 2016 - Pharmaceuticals have been beaten up from perceived policy risks, but low-cost generics won't be a target.Teva trades at lower multiples, grows faster and has less risk than the median S&P500 company.T
This Week In Pharma: Can Alder Beat Teva And Amgen In Treating Migraines? Will Positive Phase III Data Help Keryx's Auryxia Receive Approval For An Expanded Indication? http://seekingalpha.com/article/3962615-week-pharma-can-alder-beat-teva-amgen-treating-migraines-will-positive-phase-iii-data-help?source=feed_all_articles Apr 01, 2016 - This column presents questions on CGRP migraine therapies and Keryx’s Auryxia. Based on your votes for the more interesting topic, Slingshot Insights will interview an expert and post a transcript.Opt
Teva: The Future Is Generic http://seekingalpha.com/article/3961395-teva-future-generic?source=feed_tag_long_ideas Mar 28, 2016 - Drug Development Process: Teva develops their drugs in unique ways with methods that reduce risk and decrease costs.Beyond the Pill: Teva has focused on providing services that marginally improve thei
Bernard Horn Comments on Teva Pharmaceutical http://www.gurufocus.com/news/401730/bernard-horn-comments-on-teva-pharmaceutical Mar 21, 2016 - Bernard Horn Comments on Teva Pharmaceutical, Stocks: TEVA, Bernard Horn, release date:Mar 21, 2016

Pages: 1...7980818283848586

<<<Page 84>